Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health
Reference19 articles.
1. Cystic fibrosis since 1938;Davis;Am. J. Respir. Crit. Care Med.,2006
2. Cystic Fibrosis;Welsh,2011
3. Chloride channels as drug targets;Verkman;Nat Rev Drug Discov,2009
4. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N. Engl. J. Med.,2011
5. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR;Wainwright;N. Engl. J. Med.,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism;Frontiers in Pharmacology;2024-09-12
2. Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access;Clinical Pharmacology & Therapeutics;2024-02-22
3. Metabolism and pharmacokinetics of vitamin D in patients with cystic fibrosis;The Journal of Steroid Biochemistry and Molecular Biology;2023-09
4. Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort;Current Opinion in Pulmonary Medicine;2023-09-01
5. Pharmacokinetic drug-drug interactions between Paxlovid® (nirmatrelvir/ritonavir) and CFTR modulators for cystic fibrosis;Therapies;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3